From bedside to bench to clinic trials: Identifying new treatments for severe asthma

DMM Disease Models and Mechanisms

Volumn 6, Issue 4, 2013, Pages 877-888

  Mishra, Amarjit ^a   Yao, Xianglan ^a   Levine, Stewart J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYTOKINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR;

ARTICLE; ASTHMA; CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; HUMAN; NEUTROPHIL; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; HUMANS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84880011124     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.012070     Document Type: Article

References (89)

1. Anderson, G. P. (2008). Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372, 1107-1119.
2. Barlow, J. L., Bellosi, A., Hardman, C. S., Drynan, L. F., Wong, S. H., Cruickshank, J. P. and McKenzie, A. N. (2012). Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J. Allergy Clin. Immunol. 129, 191-198, e1-e4.
3. Barnes, P. J. (2008). The cytokine network in asthma and chronic obstructive pulmonary disease. J. Clin. Invest. 118, 3546-3556.
4. Barnes, P. J. (2011). Glucocorticosteroids: current and future directions. Br. J. Pharmacol. 163, 29-43.
5. Barnig, C., Cernadas, M., Dutile, S., Liu, X., Perrella, M. A., Kazani, S., Wechsler, M. E., Israel, E. and Levy, B. D. (2013). Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci. Transl. Med. 5, 174ra26.
6. Bates, J. H., Cojocaru, A., Haverkamp, H. C., Rinaldi, L. M. and Irvin, C. G. (2008). The synergistic interactions of allergic lung inflammation and intratracheal cationic protein. Am. J. Respir. Crit. Care Med. 177, 261-268. (Pubitemid 351198368)
7. Beavitt, S. J., Harder, K. W., Kemp, J. M., Jones, J., Quilici, C., Casagranda, F., Lam, E., Turner, D., Brennan, S., Sly, P. D. et al. (2005). Lyn-deficient mice develop severe, persistent asthma: Lyn is a critical negative regulator of Th2 immunity. J. Immunol. 175, 1867-1875. (Pubitemid 41023093)
8. Birrell, M. A., Battram, C. H., Woodman, P., McCluskie, K. and Belvisi, M. G. (2003). Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways. Respir. Res. 4, 3.
9. Bousquet, J. and Khaltaev, N. (2007). Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach. Geneva: World Health Organization.
10. Bousquet, J., Mantzouranis, E., Cruz, A. A., Aït-Khaled, N., Baena-Cagnani, C. E., Bleecker, E. R., Brightling, C. E., Burney, P., Bush, A., Busse, W. W. et al. (2010). Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J. Allergy Clin. Immunol. 126, 926-938.
11. Butler, C. A., McQuaid, S., Taggart, C. C., Weldon, S., Carter, R., Skibinski, G., Warke, T. J., Choy, D. F., McGarvey, L. P., Bradding, P. et al. (2012). Glucocorticoid receptor β and histone deacetylase 1 and 2 expression in the airways of severe asthma. Thorax 67, 392-398.
12. Chand, N., Harrison, J. E., Rooney, S., Pillar, J., Jakubicki, R., Nolan, K., Diamantis, W. and Sofia, R. D. (1992). Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur. J. Pharmacol. 211, 121-123.
13. Chang, Y. J., Kim, H. Y., Albacker, L. A., Baumgarth, N., McKenzie, A. N., Smith, D. E., Dekruyff, R. H. and Umetsu, D. T. (2011). Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12, 631-638.
14. Chen, C., Huang, X. and Sheppard, D. (2006). ADAM33 is not essential for growth and development and does not modulate allergic asthma in mice. Mol. Cell. Biol. 26, 6950-6956. (Pubitemid 44387643)
15. Chen, C., Kudo, M., Rutaganira, F., Takano, H., Lee, C., Atakilit, A., Robinett, K. S., Uede, T., Wolters, P. J., Shokat, K. M. et al. (2012). Integrin α9β1 in airway smooth muscle suppresses exaggerated airway narrowing. J. Clin. Invest. 122, 2916-2927.
16. Christensen, D. J., Ohkubo, N., Oddo, J., Van Kanegan, M. J., Neil, J., Li, F., Colton, C. A. and Vitek, M. P. (2011). Apolipoprotein E and peptide mimetics modulate inflammation by binding the SET protein and activating protein phosphatase 2A. J. Immunol. 186, 2535-2542.
17. Cooper, P. R., Mesaros, A. C., Zhang, J., Christmas, P., Stark, C. M., Douaidy, K., Mittelman, M. A., Soberman, R. J., Blair, I. A. and Panettieri, R. A. (2010). 20-HETE mediates ozone-induced, neutrophil-independent airway hyper-responsiveness in mice. PLoS ONE 5, e10235.
18. Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z. et al. (2011). Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 365, 1088-1098.
19. Dai, C., Yao, X., Keeran, K. J., Zywicke, G. J., Qu, X., Yu, Z. X., Dagur, P. K., McCoy, J. P., Remaley, A. T. and Levine, S. J. (2012). Apolipoprotein A-I attenuates ovalbumin-induced neutrophilic airway inflammation via a granulocyte colony-stimulating factor-dependent mechanism. Am. J. Respir. Cell Mol. Biol. 47, 186-195.
20. Dekkers, B. G., Bos, I. S., Gosens, R., Halayko, A. J., Zaagsma, J. and Meurs, H. (2010). The integrin-blocking peptide RGDS inhibits airway smooth muscle remodeling in a guinea pig model of allergic asthma. Am. J. Respir. Crit. Care Med. 181, 556-565.
21. Essilfie, A. T., Simpson, J. L., Horvat, J. C., Preston, J. A., Dunkley, M. L., Foster, P. S., Gibson, P. G. and Hansbro, P. M. (2011). Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog. 7, e1002244.
22. Essilfie, A. T., Simpson, J. L., Dunkley, M. L., Morgan, L. C., Oliver, B. G., Gibson, P. G., Foster, P. S. and Hansbro, P. M. (2012). Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 67, 588-599.
23. Fahy, J. V. (2009). Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc. Am. Thorac. Soc. 6, 256-259.
24. Fanta, C. H. (2009). Asthma. N. Engl. J. Med. 360, 1002-1014.
25. Foley, S. C., Mogas, A. K., Olivenstein, R., Fiset, P. O., Chakir, J., Bourbeau, J., Ernst, P., Lemière, C., Martin, J. G. and Hamid, Q. (2007). Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J. Allergy Clin. Immunol. 119, 863-871. (Pubitemid 46527832)
26. Grainge, C. L., Lau, L. C., Ward, J. A., Dulay, V., Lahiff, G., Wilson, S., Holgate, S., Davies, D. E. and Howarth, P. H. (2011). Effect of bronchoconstriction on airway remodeling in asthma. N. Engl. J. Med. 364, 2006-2015.
27. Grausenburger, R., Bilic, I., Boucheron, N., Zupkovitz, G., El-Housseiny, L., Tschismarov, R., Zhang, Y., Rembold, M., Gaisberger, M., Hartl, A. et al. (2010). Conditional deletion of histone deacetylase 1 in T cells leads to enhanced airway inflammation and increased Th2 cytokine production. J. Immunol. 185, 3489-3497.
28. Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J. and Green, R. H. (2008). Cluster analysis and clinical asthma phenotypes. Am. J. Respir. Crit. Care Med. 178, 218-224.
29. Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J. et al. (2009). Mepolizumab and exacerbations of refractory eosinophilic asthma. N. Engl. J. Med. 360, 973-984.
30. Hansen, G., Berry, G., DeKruyff, R. H. and Umetsu, D. T. (1999). Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103, 175-183. (Pubitemid 29053135)
31. Haworth, O., Cernadas, M., Yang, R., Serhan, C. N. and Levy, B. D. (2008). Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 9, 873-879.
32. Haworth, O., Cernadas, M. and Levy, B. D. (2011). NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation. J. Immunol. 186, 6129-6135.
33. Hayashi, N., Yoshimoto, T., Izuhara, K., Matsui, K., Tanaka, T. and Nakanishi, K. (2007). T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production. Proc. Natl. Acad. Sci. USA 104, 14765-14770. (Pubitemid 350003217)
34. Heaton, T., Rowe, J., Turner, S., Aalberse, R. C., de Klerk, N., Suriyaarachchi, D., Serralha, M., Holt, B. J., Hollams, E., Yerkovich, S. et al. (2005). An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet 365, 142-149. (Pubitemid 40091804)
35. Hew, M., Bhavsar, P., Torrego, A., Meah, S., Khorasani, N., Barnes, P. J., Adcock, I. and Chung, K. F. (2006). Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am. J. Respir. Crit. Care Med. 174, 134-141. (Pubitemid 44015386)
36. Holgate, S. T. (2012). Innate and adaptive immune responses in asthma. Nat. Med. 18, 673-683.
37. Ito, K., Herbert, C., Siegle, J. S., Vuppusetty, C., Hansbro, N., Thomas, P. S., Foster, P. S., Barnes, P. J. and Kumar, R. K. (2008). Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. Am. J. Respir. Cell Mol. Biol. 39, 543-550.
38. Kibe, A., Inoue, H., Fukuyama, S., Machida, K., Matsumoto, K., Koto, H., Ikegami, T., Aizawa, H. and Hara, N. (2003). Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am. J. Respir. Crit. Care Med. 167, 50-56. (Pubitemid 36015917)
39. Kim, E. Y., Battaile, J. T., Patel, A. C., You, Y., Agapov, E., Grayson, M. H., Benoit, L. A., Byers, D. E., Alevy, Y., Tucker, J. et al. (2008). Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 14, 633-640. (Pubitemid 351809546)
40. Kim, H. Y., DeKruyff, R. H. and Umetsu, D. T. (2010). The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat. Immunol. 11, 577-584.
41. Kim, H. Y., Chang, Y. J., Subramanian, S., Lee, H. H., Albacker, L. A., Matangkasombut, P., Savage, P. B., McKenzie, A. N., Smith, D. E., Rottman, J. B. et al. (2012). Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J. Allergy Clin. Immunol. 129, 216-227, e1-e6.
42. Kobayashi, Y., Mercado, N., Barnes, P. J. and Ito, K. (2011). Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma. PLoS ONE 6, e27627.
43. Kobayashi, M., Ashino, S., Shiohama, Y., Wakita, D., Kitamura, H. and Nishimura, T. (2012). IFN-γ elevates airway hyper-responsiveness via up-regulation of neurokinin A/neurokinin-2 receptor signaling in a severe asthma model. Eur. J. Immunol. 42, 393-402.
44. Kudo, M., Melton, A. C., Chen, C., Engler, M. B., Huang, K. E., Ren, X., Wang, Y., Bernstein, X., Li, J. T., Atabai, K. et al. (2012). IL-17A produced by γβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat. Med. 18, 547-554.
45. Lajoie, S., Lewkowich, I. P., Suzuki, Y., Clark, J. R., Sproles, A. A., Dienger, K., Budelsky, A. L. and Wills-Karp, M. (2010). Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 11, 928-935.
46. Levy, B. D., De Sanctis, G. T., Devchand, P. R., Kim, E., Ackerman, K., Schmidt, B. A., Szczeklik, W., Drazen, J. M. and Serhan, C. N. (2002). Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat. Med. 8, 1018-1023. (Pubitemid 35033707)
47. Levy, B. D., Bonnans, C., Silverman, E. S., Palmer, L. J., Marigowda, G. and Israel, E. (2005). Diminished lipoxin biosynthesis in severe asthma. Am. J. Respir. Crit. Care Med. 172, 824-830. (Pubitemid 41369064)
48. Levy, B. D., Kohli, P., Gotlinger, K., Haworth, O., Hong, S., Kazani, S., Israel, E., Haley, K. J. and Serhan, C. N. (2007a). Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J. Immunol. 178, 496-502. (Pubitemid 46039663)
49. Levy, B. D., Lukacs, N. W., Berlin, A. A., Schmidt, B., Guilford, W. J., Serhan, C. N. and Parkinson, J. F. (2007b). Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. FASEB J. 21, 3877-3884. (Pubitemid 350232345)
50. Li, J. J., Wang, W., Baines, K. J., Bowden, N. A., Hansbro, P. M., Gibson, P. G., Kumar, R. K., Foster, P. S. and Yang, M. (2010a). IL-27/IFN-γ induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages. J. Immunol. 185, 4401-4409.
51. Li, L. B., Leung, D. Y., Martin, R. J. and Goleva, E. (2010b). Inhibition of histone deacetylase 2 expression by elevated glucocorticoid receptor beta in steroid-resistant asthma. Am. J. Respir. Crit. Care Med. 182, 877-883.
52. Matangkasombut, P., Marigowda, G., Ervine, A., Idris, L., Pichavant, M., Kim, H. Y., Yasumi, T., Wilson, S. B., DeKruyff, R. H., Faul, J. L. et al. (2009). Natural killer T cells in the lungs of patients with asthma. J. Allergy Clin. Immunol. 123, 1181-1185.
53. Mauser, P. J., Pitman, A., Witt, A., Fernandez, X., Zurcher, J., Kung, T., Jones, H., Watnick, A. S., Egan, R. W., Kreutner, W. et al. (1993). Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev. Respir. Dis. 148, 1623-1627. (Pubitemid 24002499)
54. McKinley, L., Alcorn, J. F., Peterson, A., Dupont, R. B., Kapadia, S., Logar, A., Henry, A., Irvin, C. G., Piganelli, J. D., Ray, A. et al. (2008). TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 181, 4089-4097.
55. Medoff, B. D., Okamoto, Y., Leyton, P., Weng, M., Sandall, B. P., Raher, M. J., Kihara, S., Bloch, K. D., Libby, P. and Luster, A. D. (2009). Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am. J. Respir. Cell Mol. Biol. 41, 397-406.
56. Meyer, E. H., Goya, S., Akbari, O., Berry, G. J., Savage, P. B., Kronenberg, M., Nakayama, T., DeKruyff, R. H. and Umetsu, D. T. (2006). Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc. Natl. Acad. Sci. USA 103, 2782-2787.
57. Miossec, P. and Kolls, J. K. (2012). Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11, 763-776.
58. Moore, W. C., Bleecker, E. R., Curran-Everett, D., Erzurum, S. C., Ameredes, B. T., Bacharier, L., Calhoun, W. J., Castro, M., Chung, K. F., Clark, M. P. et al.; National Heart, Lung, Blood Institute's Severe Asthma Research Program (2007). Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J. Allergy Clin. Immunol. 119, 405-413. (Pubitemid 46210080)
59. Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Jr, Castro, M., Curran-Everett, D., Fitzpatrick, A. M. et al.; National Heart, Lung, and Blood Institute's Severe Asthma Research Program (2010). Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. 181, 315-323.
60. Nair, P., Pizzichini, M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E. and O'Byrne, P. M. (2009). Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N. Engl. J. Med. 360, 985-993.
61. Navab, M., Reddy, S. T., Van Lenten, B. J. and Fogelman, A. M. (2011). HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat. Rev. Cardiol. 8, 222-232.
62. Osei-Hwedieh, D. O., Amar, M., Sviridov, D. and Remaley, A. T. (2011). Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents. Pharmacol. Ther. 130, 83-91.
63. Pavord, I. D., Korn, S., Howarth, P., Bleecker, E. R., Buhl, R., Keene, O. N., Ortega, H. and Chanez, P. (2012). Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 380, 651-659.
64. Petersen, B. C., Budelsky, A. L., Baptist, A. P., Schaller, M. A. and Lukacs, N. W. (2012). Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology. Nat. Med. 18, 751-758.
65. Préfontaine, D., Lajoie-Kadoch, S., Foley, S., Audusseau, S., Olivenstein, R., Halayko, A. J., Lemière, C., Martin, J. G. and Hamid, Q. (2009). Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 183, 5094-5103.
66. Puxeddu, I., Pang, Y. Y., Harvey, A., Haitchi, H. M., Nicholas, B., Yoshisue, H., Ribatti, D., Clough, G., Powell, R. M., Murphy, G. et al. (2008). The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma. J. Allergy clin. Immunol. 121, 1400-1406, e1-e4.
67. Rangasamy, T., Guo, J., Mitzner, W. A., Roman, J., Singh, A., Fryer, A. D., Yamamoto, M., Kensler, T. W., Tuder, R. M., Georas, S. N. et al. (2005). Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J. Exp. Med. 202, 47-59. (Pubitemid 41002909)
68. Reddel, H. K., Taylor, D. R., Bateman, E. D., Boulet, L. P., Boushey, H. A., Busse, W. W., Casale, T. B., Chanez, P., Enright, P. L., Gibson, P. G. et al.; American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations (2009). An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am. J. Respir. Crit. Care Med. 180, 59-99.
69. Shannon, J., Ernst, P., Yamauchi, Y., Olivenstein, R., Lemiere, C., Foley, S., Cicora, L., Ludwig, M., Hamid, Q. and Martin, J. G. (2008). Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 133, 420-426. (Pubitemid 351272400)
70. Shore, S. A. (2010). Obesity, airway hyperresponsiveness, and inflammation. J. Appl. Physiol. 108, 735-743.
71. Shore, S. A., Schwartzman, I. N., Mellema, M. S., Flynt, L., Imrich, A. and Johnston, R. A. (2005). Effect of leptin on allergic airway responses in mice. J. Allergy Clin. Immunol. 115, 103-109. (Pubitemid 40075428)
72. Shore, S. A., Terry, R. D., Flynt, L., Xu, A. and Hug, C. (2006). Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J. Allergy Clin. Immunol. 118, 389-395. (Pubitemid 44142709)
73. Simpson, J. L., Scott, R., Boyle, M. J. and Gibson, P. G. (2006). Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 11, 54-61.
74. Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N., Mebius, R. E. et al. (2013). Innate lymphoid cells - a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149.
75. Sugimoto, T., Ishikawa, Y., Yoshimoto, T., Hayashi, N., Fujimoto, J. and Nakanishi, K. (2004). Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse. J. Exp. Med. 199, 535-545. (Pubitemid 38233837)
76. Tachdjian, R., Mathias, C., Al Khatib, S., Bryce, P. J., Kim, H. S., Blaeser, F., O'Connor, B. D., Rzymkiewicz, D., Chen, A., Holtzman, M. J. et al. (2009). Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma. J. Exp. Med. 206, 2191-2204.
77. Tatler, A. L., John, A. E., Jolly, L., Habgood, A., Porte, J., Brightling, C., Knox, A. J., Pang, L., Sheppard, D., Huang, X. et al. (2011). Integrin αvβ5-mediated TGF-β activation by airway smooth muscle cells in asthma. J. Immunol. 187, 6094-6107.
78. Terashima, A., Watarai, H., Inoue, S., Sekine, E., Nakagawa, R., Hase, K., Iwamura, C., Nakajima, H., Nakayama, T. and Taniguchi, M. (2008). A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J. Exp. Med. 205, 2727-2733.
79. Therien, A. G., Bernier, V., Weicker, S., Tawa, P., Falgueyret, J. P., Mathieu, M. C., Honsberger, J., Pomerleau, V., Robichaud, A., Stocco, R. et al. (2008). Adenovirus IL-13-induced airway disease in mice: a corticosteroid- resistant model of severe asthma. Am. J. Respir. Cell Mol. Biol. 39, 26-35. (Pubitemid 351883955)
80. Van Eerdewegh, P., Little, R. D., Dupuis, J., Del Mastro, R. G., Falls, K., Simon, J., Torrey, D., Pandit, S., McKenny, J., Braunschweiger, K. et al. (2002). Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418, 426-430. (Pubitemid 34826843)
81. Van Oosterhout, A. J., Ladenius, A. R., Savelkoul, H. F., Van Ark, I., Delsman, K. C. and Nijkamp, F. P. (1993). Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 147, 548-552. (Pubitemid 23072640)
82. Wenzel, S. (2012a). Severe asthma: from characteristics to phenotypes to endotypes. Clin. Exp. Allergy 42, 650-658.
83. Wenzel, S. E. (2012b). Asthma phenotypes: the evolution from clinical to molecular approaches. Nat. Med. 18, 716-725.
84. Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Koth, L. L., Arron, J. R. and Fahy, J. V. (2009). T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med. 180, 388-395.
85. Yang, M., Kumar, R. K. and Foster, P. S. (2009). Pathogenesis of steroid-resistant airway hyperresponsiveness: interaction between IFN-gamma and TLR4/MyD88 pathways. J. Immunol. 182, 5107-5115.
86. Yao, X., Fredriksson, K., Yu, Z. X., Xu, X., Raghavachari, N., Keeran, K. J., Zywicke, G. J., Kwak, M., Amar, M. J., Remaley, A. T. et al. (2010). Apolipoprotein E negatively regulates house dust mite-induced asthma via a low-density lipoprotein receptor-mediated pathway. Am. J. Respir. Crit. Care Med. 182, 1228-1238.
87. Yao, X., Dai, C., Fredriksson, K., Dagur, P. K., McCoy, J. P., Qu, X., Yu, Z. X., Keeran, K. J., Zywicke, G. J., Amar, M. J. A. et al. (2011a). 5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthma. J. Immunol. 186, 576-583.
88. Yao, X., Remaley, A. T. and Levine, S. J. (2011b). New kids on the block: the emerging role of apolipoproteins in the pathogenesis and treatment of asthma. Chest 140, 1048-1054.
89. Yu, M., Eckart, M. R., Morgan, A. A., Mukai, K., Butte, A. J., Tsai, M. and Galli, S. J. (2011). Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma. J. Clin. Invest. 121, 3133-3143. Institute, National Institutes of Health